Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
PDL BioPharma (United States) · Innate Pharma (France) · +1 more institution
Abstract
Gram-negative bacteria including Escherichia coli, Citrobacter rodentium, Salmonella typhimurium, and Shigella flexneri are sensed in an ill-defined manner by an intracellular inflammasome complex that activates caspase-11. We show that macrophages loaded with synthetic lipid A, E. coli lipopolysaccharide (LPS), or S. typhimurium LPS activate caspase-11 independently of the LPS receptor Toll-like receptor 4 (TLR4). Consistent with lipid A triggering the noncanonical inflammasome, LPS containing a divergent lipid A structure antagonized caspase-11 activation in response to E. coli LPS or Gram-negative bacteria. Moreover, LPS-mutant E. coli failed to activate caspase-11. Tlr4(-/-) mice primed with TLR3 agonist…
Citation impact
- FWCI
- 44.30
- Percentile
- 100%
- References
- 35
Authors
13Topics & keywords
- TLR4
- Inflammasome
- Lipopolysaccharide
- Innate immune system
- Cytoplasm
- Lipid A
- Toll-like receptor
- Intracellular